Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applications
-
- Tatsuya Ishiguro
- Department of Obstetrics and Gynecology Niigata University Medical School Niigata Japan
-
- Hirokazu Ohata
- Division of Cancer Differentiation National Cancer Center Research Institute Tokyo Japan
-
- Ai Sato
- Division of Cancer Differentiation National Cancer Center Research Institute Tokyo Japan
-
- Kaoru Yamawaki
- Department of Obstetrics and Gynecology Niigata University Medical School Niigata Japan
-
- Takayuki Enomoto
- Department of Obstetrics and Gynecology Niigata University Medical School Niigata Japan
-
- Koji Okamoto
- Division of Cancer Differentiation National Cancer Center Research Institute Tokyo Japan
この論文をさがす
抄録
<jats:p>Recently, many types of <jats:italic>in vitro</jats:italic> 3‐D culture systems have been developed to recapitulate the <jats:italic>in vivo</jats:italic> growth conditions of cancer. The cancer 3‐D culture methods aim to preserve the biological characteristics of original tumors better than conventional 2‐D monolayer cultures, and include tumor‐derived organoids, tumor‐derived spheroids, organotypic multicellular spheroids, and multicellular tumor spheroids. The 3‐D culture methods differ in terms of cancer cell sources, protocols for cell handling, and the required time intervals. Tumor‐derived spheroids are unique because they are purposed for the enrichment of cancer stem cells (<jats:styled-content style="fixed-case">CSC</jats:styled-content>s) or cells with stem cell‐related characteristics. These spheroids are grown as floating spheres and have been used as surrogate systems to evaluate the <jats:styled-content style="fixed-case">CSC</jats:styled-content>‐related characteristics of solid tumors <jats:italic>in vitro</jats:italic>. Because eradication of <jats:styled-content style="fixed-case">CSC</jats:styled-content>s is likely to be of clinical importance due to their association with the malignant nature of cancer cells, such as tumorigenicity or chemoresistance, the investigation of tumor‐derived spheroids may provide invaluable clues to fight against cancer. Spheroid cultures have been established from cancers including glioma, breast, colon, ovary, and prostate cancers, and their biological and biochemical characteristics have been investigated by many research groups. In addition to the investigation of <jats:styled-content style="fixed-case">CSC</jats:styled-content>s, tumor‐derived spheroids may prove to be instrumental for a high‐throughput screening platform or for the cultivation of <jats:styled-content style="fixed-case">CSC</jats:styled-content>‐related tumor cells found in the circulation or body fluids.</jats:p>
収録刊行物
-
- Cancer Science
-
Cancer Science 108 (3), 283-289, 2017-03
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360565168099634432
-
- ISSN
- 13497006
- 13479032
-
- データソース種別
-
- Crossref
- KAKEN